Search - tctmd.com

Displaying 61 - 80 of 251

Sort: Relevancy | Date

Presentation ISET 2019

Endovascular vs. Open Surgery of Superficial Femoral Artery Disease-The ZILVER PASS Trial

Presenter: Constantino S. Peña

January 30, 2019

Presentation ISET 2019

Drug-Coated Therapy for ISR: Review of Options and Data

Presenter: Brian DeRubertis

January 30, 2019

Presentation ISET 2019

Case-Based Tibial Arterial Disease

Presenter: Alex Powell

January 30, 2019

Presentation ISET 2019

5-Year Results from the IN.PACT SFA Randomized Trial

Presenter: Gary Ansel

January 30, 2019

News Conference News ISET 2019

Chelation for CLI in Diabetic Patients Shows Potential in Small Series

Caitlin E. Cox

January 29, 2019

News Conference News ISET 2019

PAD in the Spotlight: Awareness, Treatment Remain Low Despite Many Years of Research

Caitlin E. Cox

January 28, 2019

News Daily News

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

L.A. McKeown

January 25, 2019

Presentation LINC 2019

Femoral Popliteal DVT

Presenter: Robert Lookstein

January 25, 2019

Presentation LINC 2019

Debate: Surgical Reconstruction is Still the Gold Standard for the Common Femoral Artery

Presenter: Brian G. DeRubertis

January 25, 2019

News Daily News

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

L.A. McKeown

January 23, 2019

News Daily News

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

Caitlin E. Cox

January 10, 2019

News Daily News

AHA Scientific Statement: Get PAD Patients Moving to Improve Symptoms and QoL

L.A. McKeown

January 03, 2019

News Daily News

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

L.A. McKeown

December 18, 2018

News Daily News

Signal of Late Deaths With Paclitaxel-Coated DCBs and Stents for PAD Warrants Urgent Review, Authors Say

L.A. McKeown

December 07, 2018

Presentation Controversies and Advances 2018

Management of Severe AS Patient with Poor Access – Surgical or Percutaneous?

Presenter: Ted Feldman

November 16, 2018

News Conference News VIVA 2018

No Gender Difference in Patency Rates 1 Year After DCB for PAD: ILLUMENATE Substudy

L.A. McKeown

November 13, 2018

News Conference News VIVA 2018

Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention

L.A. McKeown

November 09, 2018

News Daily News

FDA Approves BioMimics 3D Stent for Femoropopliteal Artery Disease

Caitlin E. Cox

October 05, 2018

News Industry News

Veryan Medical receives PMA approval for BioMimics 3D

October 05, 2018

Presentation TCT Abstracts Posters 2018

Occurrence of significant mirror lesions in the lower extremity arterial disease.

Presenter: Aleksandra Kolarczyk-Haczyk1

September 25, 2018

Advertisement

Endovascular vs. Open Surgery of Superficial Femoral Artery Disease-The ZILVER PASS Trial

Drug-Coated Therapy for ISR: Review of Options and Data

Case-Based Tibial Arterial Disease

5-Year Results from the IN.PACT SFA Randomized Trial

Chelation for CLI in Diabetic Patients Shows Potential in Small Series

PAD in the Spotlight: Awareness, Treatment Remain Low Despite Many Years of Research

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

Femoral Popliteal DVT

Debate: Surgical Reconstruction is Still the Gold Standard for the Common Femoral Artery

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

AHA Scientific Statement: Get PAD Patients Moving to Improve Symptoms and QoL

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

Signal of Late Deaths With Paclitaxel-Coated DCBs and Stents for PAD Warrants Urgent Review, Authors Say

Management of Severe AS Patient with Poor Access – Surgical or Percutaneous?

No Gender Difference in Patency Rates 1 Year After DCB for PAD: ILLUMENATE Substudy

Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention

FDA Approves BioMimics 3D Stent for Femoropopliteal Artery Disease

Veryan Medical receives PMA approval for BioMimics 3D

Occurrence of significant mirror lesions in the lower extremity arterial disease.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content